Results
1 -
4 of
4Shayman J A.
ELIGLUSTAT TARTRATE: Glucosylceramide Synthase Inhibitor Treatment of Type 1 Gaucher Disease., Drugs of the future, Aug 2010 Ethylenedioxy-PIP2 Oxalate Reduces Ganglioside Storage in Juvenile Sandhoff Disease Mice, Neurochemical Research Eliglustat: First Global Approval, Drugs Case report of unexpected gastrointestinal involvement in type 1 Gaucher disease: comparison of eliglustat tartrate treatment and enzyme replacement therapy, BMC Medical Genetics